Proteomic clocks reveal biological age acceleration tied to mortality risk

Proteomic clocks expose when the body ages faster than chronological years, and that biological acceleration predicts mortality and chronic disease with precision matching conventional lifestyle indicators. In the largest prospective cohort to date—17,473 participants from the European Prospective Investigation into Cancer and Nutrition followed for 28 years—researchers mapped associations between plasma-based proteomic clocks, including organ-specific variants, and 24 incident chronic diseases. The global age acceleration score correlated strongly with smoking, alcohol consumption, physical inactivity, and elevated risk of lung, kidney, and liver cancers, alongside dementia and cardiovascular disease. Lung, kidney, and stomach cancers showed particularly tight associations with organ-specific clock acceleration. For the longevity-conscious reader, this matters: a single proteomic test functions as a molecular compass for aging, quantifying accumulated damage with higher resolution than chronological age alone, and opening the door to targeted interventions before disease manifests.